158 related articles for article (PubMed ID: 38615062)
41. Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report.
Thurberg BL
Mol Genet Metab Rep; 2020 Sep; 24():100626. PubMed ID: 32714837
[TBL] [Abstract][Full Text] [Related]
42. Functional characterization of novel variants in SMPD1 in Indian patients with acid sphingomyelinase deficiency.
Deshpande D; Gupta SK; Sarma AS; Ranganath P; Jain S JMN; Sheth J; Mistri M; Gupta N; Kabra M; Phadke SR; Girisha KM; Dua Puri R; Aggarwal S; Datar C; Mandal K; Tilak P; Muranjan M; Bijarnia-Mahay S; Rama Devi A R; Tayade NB; Ranjan A; Dalal AB
Hum Mutat; 2021 Oct; 42(10):1336-1350. PubMed ID: 34273913
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of Cancer in Acid Sphingomyelinase Deficiency.
Mauhin W; Levade T; Vanier MT; Froissart R; Lidove O
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768550
[TBL] [Abstract][Full Text] [Related]
44. Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers.
Eskes ECB; Sjouke B; Vaz FM; Goorden SMI; van Kuilenburg ABP; Aerts JMFG; Hollak CEM
Mol Genet Metab; 2020 May; 130(1):16-26. PubMed ID: 32088119
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency.
Halseth TA; Correia AB; Schultz ML; Fawaz MV; Kuiper EQ; Kumaran P; Dorsey KH; Schuchman EH; Lieberman AP; Schwendeman A
Nanomedicine; 2023 Sep; 53():102705. PubMed ID: 37633404
[TBL] [Abstract][Full Text] [Related]
46. Impact of Potential Symptoms and Risks Associated with Acid Sphingomyelinase Deficiency on Patients and Caregivers: A Best-Worst Scaling Study.
Mansfield C; Nalysnyk L; Joshi D; Coulter J; Pulikottil-Jacob R
Patient Prefer Adherence; 2023; 17():927-939. PubMed ID: 37020662
[TBL] [Abstract][Full Text] [Related]
47. Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
Diaz GA; Giugliani R; Guffon N; Jones SA; Mengel E; Scarpa M; Witters P; Yarramaneni A; Li J; Armstrong NM; Kim Y; Ortemann-Renon C; Kumar M
Orphanet J Rare Dis; 2022 Dec; 17(1):437. PubMed ID: 36517856
[TBL] [Abstract][Full Text] [Related]
48. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases.
Kuchar L; Sikora J; Gulinello ME; Poupetova H; Lugowska A; Malinova V; Jahnova H; Asfaw B; Ledvinova J
Anal Biochem; 2017 May; 525():73-77. PubMed ID: 28259515
[TBL] [Abstract][Full Text] [Related]
49. Enzyme replacement therapy for children with acid sphingomyelinase deficiency in the real world: A single center experience in Taiwan.
Pan YW; Tsai MC; Yang CY; Yu WH; Wang B; Yang YJ; Chou YY
Mol Genet Metab Rep; 2023 Mar; 34():100957. PubMed ID: 36873248
[TBL] [Abstract][Full Text] [Related]
50. Acid sphingomyelinase deficiency: The clinical spectrum of 2 patients who carry the Q294K mutation and diagnostic challenges.
Blümlein U; Mengel E; Amraoui Y
Mol Genet Metab Rep; 2022 Sep; 32():100900. PubMed ID: 36046391
[TBL] [Abstract][Full Text] [Related]
51. Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD).
Matza LS; Stewart KD; Fournier M; Rowen D; Lachmann R; Scarpa M; Mengel E; Obermeyer T; Ayik E; Laredo F; Pulikottil-Jacob R
Eur J Health Econ; 2024 Feb; ():. PubMed ID: 38409492
[TBL] [Abstract][Full Text] [Related]
52. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
53. A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results.
Wasserstein M; Lachmann R; Hollak C; Arash-Kaps L; Barbato A; Gallagher RC; Giugliani R; Guelbert NB; Ikezoe T; Lidove O; Mabe P; Mengel E; Scarpa M; Senates E; Tchan M; Villarrubia J; Chen Y; Furey S; Thurberg BL; Zaher A; Kumar M
Genet Med; 2022 Jul; 24(7):1425-1436. PubMed ID: 35471153
[TBL] [Abstract][Full Text] [Related]
54. Case Report of Gastrointestinal Bleeding in an Adult with Chronic Visceral Acid Sphingomyelinase Deficiency.
Cassiman D; Libbrecht L; Meersseman W; Wilmer A
Case Rep Gastrointest Med; 2019; 2019():9613457. PubMed ID: 31080679
[TBL] [Abstract][Full Text] [Related]
55. Morbidity and mortality in type B Niemann-Pick disease.
McGovern MM; Lippa N; Bagiella E; Schuchman EH; Desnick RJ; Wasserstein MP
Genet Med; 2013 Aug; 15(8):618-23. PubMed ID: 23412609
[TBL] [Abstract][Full Text] [Related]
56. Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency.
Di Rocco M; Vici CD; Burlina A; Venturelli F; Fiumara A; Fecarotta S; Donati MA; Spada M; Concolino D; Pession A
Orphanet J Rare Dis; 2023 Jul; 18(1):197. PubMed ID: 37480063
[TBL] [Abstract][Full Text] [Related]
57. Limited benefits of presymptomatic cord blood transplantation in neurovisceral acid sphingomyelinase deficiency (ASMD) intermediate type.
Mercati O; Pichard S; Ouachée M; Froissart R; Fenneteau O; Roche B; Elmaleh-Bergès M; Bertrand Y; Ogier de Baulny H; Vanier MT; Schiff M
Eur J Paediatr Neurol; 2017 Nov; 21(6):907-911. PubMed ID: 28801223
[TBL] [Abstract][Full Text] [Related]
58. Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B).
Thurberg BL; Wasserstein MP; Schiano T; O'Brien F; Richards S; Cox GF; McGovern MM
Am J Surg Pathol; 2012 Aug; 36(8):1234-46. PubMed ID: 22613999
[TBL] [Abstract][Full Text] [Related]
59. Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months.
Wasserstein MP; Diaz GA; Lachmann RH; Jouvin MH; Nandy I; Ji AJ; Puga AC
J Inherit Metab Dis; 2018 Sep; 41(5):829-838. PubMed ID: 29305734
[TBL] [Abstract][Full Text] [Related]
60. Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population.
Cerón-Rodríguez M; Vázquez-Martínez ER; García-Delgado C; Ortega-Vázquez A; Valencia-Mayoral P; Ramírez-Devars L; Arias-Villegas C; Monroy-Muñoz IE; López M; Cervantes A; Cerbón M; Morán-Barroso VF
Ann Hepatol; 2019; 18(4):613-619. PubMed ID: 31122880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
